KPIs & Operating Metrics(New)
Growth Metrics

Colgate Palmolive (CL) Common Equity (2016 - 2025)

Colgate Palmolive has reported Common Equity over the past 17 years, most recently at $54.0 million for Q4 2025.

  • Quarterly results put Common Equity at $54.0 million for Q4 2025, down 74.53% from a year ago — trailing twelve months through Dec 2025 was $54.0 million (down 74.53% YoY), and the annual figure for FY2025 was $54.0 million, down 74.53%.
  • Common Equity for Q4 2025 was $54.0 million at Colgate Palmolive, down from $1.2 billion in the prior quarter.
  • Over the last five years, Common Equity for CL hit a ceiling of $4.0 billion in Q1 2024 and a floor of -$25.1 billion in Q4 2022.
  • Median Common Equity over the past 5 years was $1.2 billion (2025), compared with a mean of -$786.9 million.
  • Biggest five-year swings in Common Equity: soared 39900.0% in 2021 and later tumbled 472.91% in 2022.
  • Colgate Palmolive's Common Equity stood at -$4.4 billion in 2021, then tumbled by 472.91% to -$25.1 billion in 2022, then soared by 105.83% to $1.5 billion in 2023, then plummeted by 85.54% to $212.0 million in 2024, then crashed by 74.53% to $54.0 million in 2025.
  • The last three reported values for Common Equity were $54.0 million (Q4 2025), $1.2 billion (Q3 2025), and -$3.9 billion (Q2 2025) per Business Quant data.